3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
2
Plasma cell
1
Other hematologic neoplasm
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Thyroid Neoplasms
2
Thyroid Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Papillary Thyroid Microcarcinoma
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
HIV Infections
1
Colorectal Neoplasms
1
Coitus
1
Breast Neoplasms
1
Interventions
pembrolizumab
9
Nivolumab
5
epacadostat
2
Thiotepa
2
Nonlinear Optical Microscopy
2
Magnetic Resonance Spectroscopy
2
Magnetic Resonance Imaging
2
Ipilimumab
2
Filgrastim
2
Cytological Techniques
2
Cyclophosphamide
2
Biopsy, Fine-Needle
2
Biopsy
2
vocimagene amiretrorepvec
1
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
spartalizumab
1
sapanisertib
1
romidepsin
1
relatlimab
1
poly ICLC
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
motexafin gadolinium
1
larotrectinib
1
ipatasertib
1
fludarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
Focus Groups
×
Head & Neck
×
Clear all
NCT06236373
2024-12-09
Survivorship
University of Modena and Reggio Emilia
Recruiting
45 enrolled